Destructive pneumonias in children

Cover Page

Abstract


Purpose. A complicated acute destructive pneumonia is one of the most severe purulent and septic diseases in children. The issue is pressing as a high level of lungs and pleura purulent morbidity among different age groups has been preserved till now. Materials and methods. The article reviews Russian and foreign literature addressing the issues of destructive pneumonia epidemiology, reviewing etiological aspects of the disease and analyzing the most frequent pathological agents which result in destructive pneumonia. Moreover, the authors’ views on pathogenesis and pathomorphology of this disease and its clinical signs are presented. Effectiveness of diagnostic research methods in diagnosis verification is comparatively assessed. A special attention is given to various methods of antibacterial therapy and prevention of this severe disease. Conclusions. The authors conclude that destructive pneumonia is a severe complication of pneumonia in children. S. pneumoniae and S. Aureus refer to its basic causative agents. Further studies need to establish the host-pathogen interaction, improve the microbiological diagnosis and optimize conservative and surgical treatment.

About the authors

V. A. Vecherkin

Voronezh State Medical University named after N. N. Burdenko

Author for correspondence.
Email: vecherkinva@mail.ru

Russian Federation

Vladimir А. VECHERKIN – Dr. Sci (Med), Professor, Head of Department of pediatric surgery

Studencheskaya st. 10, Voronezh, 394036
+7(473) 237–28–32 

D. A. Toma

Voronezh State Medical University named after N. N. Burdenko

Email: fake@neicon.ru

Russian Federation

Dmitriy A. TOMA – Graduate student of the Department of Pediatric Surgery

Studencheskaya st. 10, Voronezh, 394036

V. A. Ptitsyn

Voronezh State Medical University named after N. N. Burdenko

Email: fake@neicon.ru

Russian Federation

Vladimir A. PTITSYN – Cand. Sci. (Med), Associate professor, at the Department of Pediatric Surgery

Studencheskaya st. 10, Voronezh, 394036

P. V. Koryashkin

Voronezh State Medical University named after N. N. Burdenko

Email: fake@neicon.ru

Russian Federation

Pavel V. KORYASHKIN – Assistant of the Department of Pediatric Surgery

Studencheskaya st. 10, Voronezh, 394036

References

  1. Грона В. Н., Сопов Г. А.. Клинические проявления, диагностика и лечение бактериальной деструкции легких у детей. Журнал Здоровье ребенка. 2008;1(10):43–46. http://www.mif-ua.com/archive/article_print/4346
  2. Разумовский, А.Ю., Аллаберганов К. О., Рачков В. Е., Алхасов М. Б. Оценка эффективности различных методов диагностики острых гнойно-воспалительных заболеваний легких и плевры у детей. Педиатрия. 2006; (1): 57–59
  3. Хаспеков Д. В., Ольхова Е. Б., Топилин О. Г., Сафин Д. А., Ткаченко Н. В. Соколов Ю. Ю. Современные методы диагностики и лечения деструкивиной пневмонии у детей. Российский вестник детской хирургии анестезиологии и реаниматологии. 2015;5(2): 7–12
  4. Griffin M. R., Zhu Y., Moore M. R., Whitney C. G., Grijalva C. G. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N. Engl. J. Med. 2013;369:155–63. doi: 10.1056/NEJMoa1209165
  5. Jardine A., Menzies R. I., McIntyre P. B. Reduction in hospitalizations for pneumonia associated with the introduction of a pneumococcal conjugate vaccination schedule without a booster dose in Australia. Pediatr. Infect. Dis. J. 2010; 29:607–12. doi: 10.1097/INF.0b013e3181d7d09c
  6. Sgambatti S., Minamisava R., Bierrenbach A. L. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance. Vaccine. 2016; 34:663–70. doi: 10.1016/j.vaccine.2015.12.007
  7. Strachan R., Jaffe A. Assessment of the burden of paediatric empyema in Australia. J. Paediatr. Child Health. 2009; 45:431–6. doi: 10.1111/j.1440–1754.2009.01533.x
  8. Grijalva C. G., Zhu Y., Nuorti J. P., Griffin M. R. Emergence of parapneumonic empyema in the USA. Thorax. 2011; 66:663–8. doi: 10.1136/thx.2010.156406
  9. Grijalva C. G., Nuorti J. P., Zhu Y., Griffin M. R. Increasing incidence of empyema complicating childhood communityacquired pneumonia in the United States. Clin. Infect Dis. 2010; 50:805–13. doi: 10.1086/650573
  10. Byington C. L., Hulten K. G., Ampofo K. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J. Clin. Microbiol. 2010; 48:520–5. doi: 10.1128/JCM.01200–09
  11. Hsieh Y. C., Wang C-W., Lai S-H., Lai J-Y, Wong K-S, Huang Y-C. Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan. Pediatr. Infect. Dis. J. 2011; 30:740–4. doi: 10.1097/INF.0b013e31821b10c3
  12. Ramphul N., Eastham K. M., Freeman R., Eltringham G., Kearns A. M., Leeming J. P. Cavitatory lung disease complicating empyema in children. Pediatr. Pulmonol. 2006; 41:750–3. doi: 10.1002/ppul.20434
  13. McKee A.J., Ives A., Balfour-Lynn I. M. Increased incidence of bronchopulmonary fistulas complicating pediatric pneumonia. Pediatr. Pulmonol. 2011; 46:717–21. doi: 10.1002/ppul.21396
  14. Lemaitre C., Angoulvant F., Gabor F., Makhoul J., Bonacorsi S., Naudin J. Necrotizing pneumonia in children. Report of 41 cases between 2006 and 2011 in a French tertiary care center. Pediatr. Infect. Dis. J. 2013; 32:1146–9. doi: 10.1097/INF.0b013e31829be1bb
  15. Sawicki G. S., Lu F. L., Valim C., Cleveland R. H., Colin A. A. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur. Respir. J. 2008; 31:1285–91. doi: 10.1183/09031936.00099807
  16. Obando I., Valderrabanos E. S., Millan J. A., Neth O. W. Necrotizing pneumonia due to influenza a (H1N1) and communityacquired methicillin-resistant Staphylococcus aureus clone USA300: successful management of the first documented pediatric case. Arch. Dis. Child. 2010; 95:305–6.
  17. Spencer D. A., Thomas M. F. Necrotizing pneumonia in children. Pediatr. Respir. Rev. 2014; 15:240–5.
  18. Jauneikaite E., Tocheva A. S., Jefferies J. M. Current methods for capsular typing of Streptococcus pneumoniae. J. Microbiol. Methods. 2015; 113:41–9. doi: 10.1016/j.mimet.2015.03.006
  19. Kerem E., Bar Ziv. Y., Rudenski B., Katz S., Kleid D., Branski D. Bacteremic necrotizing pneumococcal pneumonia in children. Am. J. Respir. Crit. Care. Med. 1994; 149:242–4. doi: 10.1164/ajrccm.149.1.8111589
  20. Chen J., Luo Y., Zhang S., Liang Z., Wang Y., Zhang T. Community-acquired necrotizing pneumonia caused by methicillinresistant Staphylococcus aureus producing Panton-valentine leucocidin in a Chinese teenager: case report and literature review. Int. J. Infect. Dis. 2014; 26:17–21. doi: 10.1016/j.ijid.2014.02.025
  21. Linares J., Ardunay C., Pallares R., Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin. Microbiol. Infect. 2010; 16:402–10. doi: 10.1111/j.1469–0691.2010.03182.x
  22. Reinert R. R., Jacobs M. R., Kaplan S. L. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine. 2010; 28:4249–59. doi: 10.1016/j.vaccine.2010.04.020
  23. Dayan G. H., Mohamed N., Scully I. L. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Rev. Vaccines. 2016; 11:1373–92. doi: 10.1080/14760584.2016.1179583
  24. Schwartz K. L., Nourse C. Panton-valentine leucocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature. Eur. J. Pediatr. 2012; 171:711–7. doi: 10.1007/s00431–011–1651-y
  25. Gillet Y., Vanhems P., Lina G. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-valentine leucocidin. Clin. Infect. Dis. 2007; 45:315–21. doi: 10.1086/519263
  26. Loffler B., Hussain M., Grundmeler M. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathogens 2010; 6(1): e1000715.
  27. Shallcross L. J., Fragaszy E., Johnson A. M., Hayward A. C. The role of the Panton-valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet. Infect. Dis. 2013; 13:43–54. doi: 10.1016/S1473–3099(12)70238–4
  28. Sicot N., Khanafer N., Meyssonnier V. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia – results of a prospective observational study. Clin. Microbiol. Infect. 2013;19: e142–8. doi: 10.1111/1469–0691.12022
  29. Tong S. Y., Davis J. S., Eichenberger E., Holland T. L., Fowler V. G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015; 28:603–61. doi: 10.1128/CMR.00134–14
  30. Chatha N., Fortin D., Bosma K. J. Management of necrotizing pneumonia and pulmonary gangrene: a case series and review of the literature. Can. Respir. J. 2014; 21:239–45. doi: 10.1155/2014/864159
  31. Amorim P., Morcillo A. M., Tresoldi A. T., Fraga Ade. M., Pereira R. M., Baract E. C. Factors associated with complications of community-acquired pneumonia in preschool children. J. Bras. Pneumonol. 2012; 38:614–21. doi: 10.1590/S1806–37132012000500011
  32. Yazer J., Giacomantonio M., MacDonald N., Lopushinsky S. Severe necrotizing pneumonia in a child with pandemic (H1N1) influenza. Can. Med. J. 2011; 183:215–9. doi: 10.1503/cmaj.100285
  33. Janapatla R. P., Hsu M. H., Hsieh Y. C., Lee H. Y., Lin T. Y., Chiu C. H. Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children. Clin. Microbiol. Infect. 2013; 19:480–6. doi: 10.1111/j.1469–0691.2012.03894.x
  34. Bosch A. A., Biesbroek G., Trzcinski K., Sanders E. A., Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013; 9: e1003057. doi: 10.1371/journal.ppat.1003057
  35. Loizzi M., De Palma A., Pagliarulo V., Loizzi D., Sollitto F. Pulmonary infections of surgical interest in childhood. Thorac. Surg. Clin. 2012; 22:387–401. doi: 10.1016/j.thorsurg.2012.04.005
  36. Hacimustafaoglu M., Celebi S., Sarimehmet H., Gurpinar A., Ercan I. Necrotizing pneumonia in children. Acta. Paediatr. 2004; 93:1172–7. doi: 10.1111/j.1651–2227.2004.tb02744.x
  37. Thomas M. F., Wort A., Spencer D. A. Management and complications of pneumonia. Pediatr. Child. Health. 2014;25:172–8. doi: 10.1016/j.paed.2014.11.004
  38. Sly P. D., Zar H. J. The spectrum of lower respiratory tract illness in children after pneumococcal conjugate vaccination. Am. J. Respir. Crit. Care. Med. 2017; 195:13–5. doi: 10.1164/rccm.201607–1461ED
  39. Lemaitre C., Angoulvant F., Gabor F., Makhoul J., Bonacorsi S., Naudin J. Necrotizing pneumonia in children. Report of 41 cases between 2006 and 2011 in a French tertiary care center. Pediatr. Infect. Dis. J. 2013; 32:1146–9. doi: 10.1097/INF.0b013e31829be1bb
  40. De Schutter I., Vergison A., Tuerlinckx D. Pneumococcal aetiology and serotype distribution in paediatric communityacquired pneumonia. PLoS One. 2014; 9: e89013. doi: 10.1371/journal.pone.0089013
  41. Torrses A., Lee N., Cilloniz C., Vila J., Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur. Respir. J. 2016;48:1764–78. doi: 10.1183/13993003.01144–2016
  42. Murdoch D. R. How to best determine causative pathogens in pneumonia. Pneumonia. 2016; 8:1. doi: 10.1186/s41479016–0004-z
  43. Brealey J. C., Sly P. D., Young P. R., Chappell K. J. Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiol. Lett. 2015; 362 р.
  44. Vaideeswar P., Bavdekar S. B., Jadhav S. M., Balan.R, Pandit S. P. Necrotizing adenoviral pneumonia: manifestation of nosocomial infection in pediatric intensive care unit. Ind. J. Pediatr. 2008; 75:1171–4. doi: 10.1007/s12098–008–0177–4
  45. Torrses A., Lee N., Cilloniz C., Vila J., Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur. Respir. J. 2016; 48:1764–78. doi: 10.1183/13993003.01144–2016
  46. Islam S., Calkins C. M., Goldin A. B. The diagnosis and management of empyema in children: a comprehensive review from the APSA outcomes and clinical trial committee. J. Pediatr. Surg. 2012; 47:2101–10. doi: 10.1016/j.jpedsurg.2012.07.047
  47. Lai S. H., Wong K. S., Liao SL. Value of lung ultrasonography in the diagnosis and outcome prediction of pediatric community-acquired pneumonia with necrotizing change. PLoS One 2015; 10(6): e0130082.
  48. Shaughnessy E. E., Stalets E. L., Shah S. S. Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era. Curr. Opin. Pediatr. 2016; 28:786–93. doi: 10.1097/MOP.0000000000000428
  49. Izadnegahdar R., Cohen A. L., Klugman K. P., Qazi S. A. Childhood pneumonia in developing countries. Lancet. Respir. Med. 2013; 1:574–84. doi: 10.1016/S2213–2600(13)70075–4

Statistics

Views

Abstract - 85

PDF (Russian) - 0

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies